Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
In this thought-provoking book, leading experts explore why international entrepreneurship is important to the life sciences industry. From multi-disciplinary and cross-national perspectives, they question why international entrepreneurship scholars might usefully invest interest in research focused on one specific industry context. The book addresses contemporary challenges of relevance to life science firms and draws on leading-edge debates in international entrepreneurship research. Topics include: the nature of the born-global firm; the development of international capabilities and competencies; the role of local and international partnerships and alliances; competitiveness, opportunity recognition and orientation; and the role of specialized complementary assets in internationalization. It concludes by proposing an agenda for future research across the underpinning fields of innovation, entrepreneurship and internationalization. This book will prove a stimulating read for academics, students and researchers with an interest in international business, management and entrepreneurship, as well as for practitioners in the health professions or life sciences academics who are, or may become, entrepreneurs.
Edited by Marian V. Jones, Professor of International Enterprise, The University of Sheffield Management School, Colin Wheeler, Professor of Marketing, Portsmouth Business School, UK and the late Pavlos Dimitratos, formerly Assistant Professor, Athens University of Economics and Business, Greece and Senior Research Fellow (on a visiting basis), CIER, Business School, University of Glasgow, UK
Contents:Introduction: International Entrepreneurship in the Life SciencesMarian V. Jones, Colin Wheeler and Pavlos DimitratosPART I: NEW VENTURE ATTRIBUTES AND DEVELOPMENT CAPABILITIES2. Assessing the Internationalization Capabilities of Life Science New VenturesMarian V. Jones, Colin Wheeler, Pavlos Dimitratos and George Vlachos3. Differences in the Strategic Orientations of Nordic and US-based Young Biotechnology VenturesMaija Renko4. Small Pharmaceutical Firms Building Capabilities to Compete Along the Global Research and Development PipelineLisette Pregelj, Martie-Louise Verreynne and Damian HinePART II: THE ROLE AND ESTABLISHMENT OF PARTNERSHIPS5. Partnership Formation in Small Biotech CompaniesNiina Nummela and Outi Nurminen6. Collaborative Entrepreneurship and Internationalization in Life Sciences: Global Growth through Collaboration in Italian Biotech FirmsAntonella Zucchella and Diala Kabbara7. Alliance-driven Governance in the Scottish Life Sciences and its Contribution to Regional DevelopmentKean Birch and Andrew CumbersPART III: DEVELOPING CAPABILITIES AND COMPETENCIES FOR INTERNATIONALIZATION8. Sub-suppliers in the Life Science Industry: The Case of Two Danish University Spin-offsErik S. Rasmussen, Martin Hannibal, René Lydiksen and Per Servais9. Rapid Internationalization and Sustained Competitive Advantage in US and UK Life Science International New Ventures: A Resource-based ViewKarl Warner and Jon Carrick10. Intellectual Property Protection: The Case of Three Swiss Life Science SMEsMarcus Matthias Keupp, Sascha Friesike and Oliver GassmannPART IV: GROWTH, PERFORMANCE AND INTERNATIONALIZATION11. Performance Trade-offs: Success, Revenue and ProfitabilityColin Wheeler, Marian V. Jones, George Vlachos and Pavlos Dimitratos12. Internationalization of Life Science Firms: Dynamics in the Interaction between Networks, Innovation and Export PerformanceVandana Ujjual13. Firm Growth and Performance in Biotechnology: Financial Facts or Wishful Thinking?Malin Brännback, Alan L. Carsrud and Niklas Kiviluoto14. A Model of Decision-making Processes in Internationalized Life Science FirmsPavlos Dimitratos, Marian V. Jones and Colin Wheeler15. Towards a Research Agenda for International Entrepreneurship in the Life SciencesMarian V. Jones, Colin Wheeler and Pavlos DimitratosReferencesIndex
'The processes of internationalization, innovation and venture-creation in high-technology new ventures are inextricably intertwined. This is particularly true in the uncertain and troubled waters of the life sciences industry where startups with very uncertain futures are required to face significant challenges in short windows of opportunity. Navigating these waters is not straightforward, neither for those immediately involved in it, nor for those trying to understand it. This book is a must-read for anyone who is serious about understanding entrepreneurship in the biotechnology industry.'- Alberto Onetti, CrESIT (Research Center for Innovation and Life Science Management), Italy